Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.64
-0.12 (-0.87%)
At close: Sep 10, 2025, 3:59 PM
13.64
0.00%
After-hours: Sep 10, 2025, 04:04 PM EDT
Theravance Biopharma Revenue
Theravance Biopharma reported an annual revenue of $64.38M, reflecting a 12.12% growth. For the quarter ending June 30, 2025, Theravance Biopharma generated $26.2M in revenue.
Revenue (ttm)
64.38M
Revenue Growth
12.12%
Price / Sales Ratio
7.14
Revenue / Employee
663.72K
Employees
97
Market Cap
686.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 64.38M | +12.12% |
| Dec 31, 2023 | 57.42M | +11.84% |
| Dec 31, 2022 | 51.35M | -7.17% |
| Dec 31, 2021 | 55.31M | -23.03% |
| Dec 31, 2020 | 71.86M | -2.12% |
| Dec 31, 2019 | 73.41M | +21.61% |
| Dec 31, 2018 | 60.37M | +292.37% |
| Dec 31, 2017 | 15.39M | -68.37% |
| Dec 31, 2016 | 48.65M | +15.48% |
| Dec 31, 2015 | 42.13M | +260.42% |
| Dec 31, 2014 | 11.69M | +5071.68% |
| Dec 31, 2013 | 226K | -99.83% |
| Dec 31, 2012 | 130.15M | +776.16% |
| Dec 31, 2011 | 14.85M | n/a |